At Nobel Journal of Health Sciences (NJHS), we are committed to protecting your privacy and ensuring the security of your personal information. This Privacy Policy outlines how we collect, use, and safeguard your data when you visit our website or interact with our services.
We are open access journal such that all the viewer can be freely access, download, share and re-use all published contents of this journal without prior approval from us or author; which will accelerate research, enrich education and greater global exchange of knowledge. All published articles in the Nobel Journal of Health Sciences (NJHS) are promptly and permanently available online after the completion of the publication process with Crossref indexing. All the published contents are distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0)
Our editorial policies are carefully designed to maintain the highest standards of scholarly publishing, creating a dynamic and inclusive environment for the sharing of innovate research in health science. This comprehensive overview delves into the fundamental principles that guide our editorial decision-making, ethical considerations, peer review processes, and commitment to transparency.
We are dedicated to upholding editorial independence, which means that decisions about submitted manuscript about acceptance, rejection, or revision are based solely on academic merit. This editorial autonomy is essential for preserving the integrity of the peer review process and the editorial decision making process.
All submissions are subjected to a fair, unbiased, and rigorous evaluation process. Our editors focus on the scientific quality, originality, and significance of each manuscript, regardless of authors' affiliations, backgrounds, or other non-scientific factors.
We follow to a rigorous peer review process, employing experts in the respective fields of health science to evaluate the submitted manuscript. This process ensures that published articles meet high scientific standards and provide valuable insights to the scholarly community.
The Nobel Journal of Health Sciences (NJHS) adheres to the double-blind peer review process, ensuring that both the author(s) and reviewers remain unware of each other’s identity, thereby preserving the confidentiality of the peer review process.
We are committed to providing authors with timely and constructive feedback, minimizing the time between submission and final editorial decisions. This commitment aligns with our goal of supporting researchers in the prompt dissemination of their findings.
We follow established ethical guidelines and encourage the responsible conduct of research, including proper citation of sources, avoidance of plagiarism, and accurate reporting of methodologies and results. We also expected same from the author(s) to uphold the highest standards of research integrity.
We follow the ICMJE guideline on authorship and it should be based on substantial contributions to the conception, design, execution, or interpretation of the research. For group authorship, we request author statement file outlining their individual intellectual contribution of the work to emphasize the importance of transparent authorships. We seriously regret the practice of 3G (ghost authorship, gifted authorship and guest authorship). Any published article(s) in NJHS if found these practices will be immediately suspended and authors are blacklisted. The author(s) are of three types; first author, corresponding author and coauthor(s).
We are committed to transparency regarding potential conflicts of interest. Authors must disclose any financial or personal relationships with other people or organizations that may inappropriately influence or biasness of their research findings. For example, employment, consultancies, paid expert testimony, patent applications or registrations, grants or other findings. Editors and reviewers are also expected to declare any conflicts of interest that may compromise impartial decision-making.
Authors are responsible for ensuring that their work is free from plagiarism, and any instances of misconduct are treated with the utmost seriousness. If plagiarism is detected after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the author’s rebuttal is not found to be satisfactory, the manuscript will be retracted and the author (s) will be blacklisted.
The guidelines for manuscript preparation of manuscript are available in the author’s instruction. These guidelines address formatting, referencing, and other essential elements to ensure a standardized and streamlined publication process.
We kindly request that all the author(s) provide ethical approval from the Institutional Review Board and informed consent forms from participants at the time of manuscript submission. This commitment to ethical research practices highlight the Nobel Journal of Health Sciences (NJHS)'s dedication to the welfare of research participants.
We encourage all the authors to share their research data, code, and other relevant materials to promote transparency and reproducibility.
The Editorial board of the Nobel Journal of Health Sciences (NJHS) regularly reviews and refines its editorial policies to align with evolving standards and best practices in scholarly publishing. We actively seek feedback from authors, reviewers, and readers to guide our continuous improvement efforts.
Nobel Journal of Health Sciences (NJHS) welcome other journals, institutions, and organizations to foster innovation and uphold the highest standards in scholarly publishing.
All manuscripts submitted to NJHS are subjected to a rigorous peer-review process. After passing initial checks, the manuscript will be reviewed by three independent experts. The review process follows a double-blind model, where reviewers and author(s) are not aware of each other’s identities. The comments from the peer-review are confidential and disclosed only with the explicit consent of the reviewer.
An electronic invitation will be sent to the relevant subject experts including the title, abstract, and keywords of the manuscript for review. Upon acceptance, a 28 days’ timeframe is assigned to the reviewers to complete the review process. After this period, reviews become overdue. In the case of non-response, the manuscript invitation is withdrawn, and an alternative reviewer is approached.
The corresponding author will receive an email once the reviewers submit their comments to the Nobel Journal of Health Sciences (NJHS). The Editor checks the comments and forwards them to the corresponding author, with or without additional remarks. The corresponding author must resubmit the revised manuscript, addressing both editorial and reviewer comments, within two weeks. Failure to submit the revised version within the stipulated timeframe results in the article being considered rejected, and its metadata will be removed from the system.
Nobel Journal of Health Sciences (NJHS) requires all authors and peer reviewers to declare any conflict of interest associated with the submission or review of an article. Authors are requested to follow ethical standards as prescribed by COPE. We adopt the Uniform Requirements for Manuscripts Submitted to Biomedical Journals 2001, as adopted by the International Committee of Medical Journal Editors (ICMJE)
Authors must disclose all financial and personal relationships that could potentially bias their work. Financial relationships such as employment, consultancies, stock ownership, honoraria, paid expert testimony represents the most identifiable conflicts of interest and are the most likely to compromise the credibility of the journal. To avoid ambiguity, authors must explicitly indicate in the letter accompanying their submitted manuscript whether any potential conflicts of interest exist.
Manuscript from human participants must include a statement in the Methods section that participants gave their informed consent. It is journal policy that participant anonymity must be preserved in all cases. For experimental, clinical, and drug research, an Ethics Committee report consistent with international agreements on human rights (Helsinki Declaration) and an informed consent of patients are required.
Authors must disclose all sources of funding for their research. This includes funding from government agencies, private industry, and non-profit organizations. Authors should also disclose any financial relationships with organizations that could be perceived as influencing their work.
Authors must conduct a thorough risk assessment for their research, particularly for studies involving human participants or sensitive data. This assessment should identify potential risks to participants and outline strategies for mitigating these risks. Authors are responsible for ensuring that their research complies with all relevant ethical guidelines and regulations.
The publication of an article in a peer-reviewed journal is a crucial element in promoting a comprehensible and trusted network of information that ultimately enhances the quality of knowledge. Hence, all submitted manuscripts undergo expert peer review. We employ a double-blind peer-review system, with two to three referees (members of the Editorial Committee and/or external consultants) independently evaluating each manuscript. The referees will provide recommendation regarding acceptance, revision or rejection of the manuscript. In certain cases, specialist peer reviewers (such as statisticians) will be consulted to review specific aspects, such as study design, conduct of the study, data presentation, statistical analysis, or conclusions. If the referees suggest revision for that manuscript, authors will be requested to revise the manuscript along the lines indicated by the referees. The resubmitted manuscripts will also undergo further peer review. Once the revisions are completed and approved by the Managing Editor, the corresponding author will be notified that the article has been accepted for publication. Rejected manuscripts will be returned to the authors but their metadata will remain in the system. The average time from manuscript acceptance to publication is three months.
Authors must ensure that they have written (currently we accept manuscript written in English) original works and declared that the submitted manuscript has not been published elsewhere or has not submitted to any other journal for considering publication. Any work or words from other authors, contributors, or sources should be appropriately credited and referenced. Those submitting their works to the journal as original articles confirm that the submitted manuscript represents their contributions and have not been copied or plagiarized, in whole or in part, from other works without clear citation. All authors should disclose any financial or other conflict of interest that might influence the results or interpretation of their manuscript. When an author discovers a significant error or inaccuracy in their own published work, it is the author’s obligation to promptly notify the journal editor and cooperate in correcting the manuscript. Author(s) must agree to the license agreement before submitting their articles. All articles must be submitted using the online submission procedure.
Editors are responsible for conducting a fair double-blind peer review of submitted manuscript intended for publication. They will actively work to prevent any potential conflicts of interest between the author and the editorial and review personnel. Additionally, editors must ensure that all information related to submitted manuscripts remains confidential until publication. The editor-in-Chief will coordinate the activities of editorial team.
We request all the reviewers to evaluate the submitted manuscripts based on their contents which cover following points. a. Originality of the manuscript and is the content scientifically acceptable or not b. Ethical compliance c. Study plan, methods and use of appropriate statistical tool d. Citation and conclusion appropriate or not e. Does the title reflect the content?
It is the responsibility of reviewer to maintain the confidentiality related to submitted manuscripts. In case of rejection, the reviewer must show the ground of rejection. If a reviewer feels unable or unqualified to review the manuscript or knows that a prompt review will be impossible, they should notify the Editor-in-Chief.
We commit to the highest standards of publication ethics and takes all measures against any publication malpractices. All parties involved in publishing - the authors, the journal editors, the peer reviewers and the publisher - agree with standards of ethical behavior.
We are committed to ensuring the highest standards of integrity, transparency, and objectivity in the scientific research we publish. So, we request comprehensive disclosure from all authors, reviewers, and editors regarding any potential conflicts of interest that could impact their contributions. Additionally, to mitigate conflicts of interest, we undergo regular updates to ensure our practices remain effective and relevance, addressing new challenges and aligning with the latest tools in scientific publication.
A conflict of interest arises when the personal, financial, or professional interests of individuals involved in the publication process could potentially or perceptibility influence an individual’s judgement and objectivity. It may be real or perceived and may involve authors, editors, reviewers, or any other parties contributing to the publication process.
The authors must disclose any potential conflicts of interest that could influence the research, its interpretation, or the presentation of their findings. This includes financial interests, affiliations, or relationships with organizations that may have a direct or indirect interest in the submitted content.
We request all authors to provide transparent information about funding sources for their research. Full disclosure of financial support, grants, or any other financial relationships that may have influenced the research is essential. This transparency allows readers and reviewers to assess the potential impact of funding sources on the study.
In cases of conflicts of interest, it is the responsibility of authors for mitigation and manage these conflicts which include clear disclosure statements within the manuscript, acknowledgment of potential biases, or other measures to ensure transparency.
Editors at the Nobel Journal of Health Sciences (NJHS) are responsible for evaluating submitted manuscripts objectively without bias. They should recuse themselves from handling a manuscript in case of any relation to personal, financial, or professional relationship with the authors that could compromise their impartiality.
The scientific merit and alignment of the journal’s aims and scope are prime factors in making fair decisions. If conflicts arise during the review process, editors should take appropriate actions, which may include seeking additional reviews or consulting with other members of the editorial board.
In cases where editors have conflicts of interest, it is essential to maintain transparency in the decision-making process. Editors must clearly communicate any potential conflicts and actively work to minimize their effects, ensuring that the publication process remains fair and unbiased.
Reviewers are essential for upholding the integrity of the peer-review process. They should evaluate manuscripts objectively, without personal, financial, or professional biases that could affect their assessment.
It is the responsibility of reviewers to disclose any conflicts of interest to the editorial team. If a potential conflict arises after accepting a review assignment, reviewers should inform the editor immediately, so that appropriate actions, such as reassignment of the review, can be taken.
Reviewers are expected to maintain confidentiality and integrity throughout the review process. Any information obtained during this review process must be handled responsibly, and reviewers should refrain using unpublished information for personal gain or biased decision-making.
Publisher of the Nobel Journal of Health Sciences (NJHS) is committed to maintaining transparency in its operations. We understand that any potential conflicts of interest involving the publisher, editorial team, or other stakeholders can impact the publication process.
Editorial independence is essential, and decisions are made without any external influences. The acceptance or rejection of a manuscript is based on the quality of the research paper and its alignment with the journal’s aim and scope.
The conflict resolution process involves a thorough investigation, consultation with relevant parties, and the implementation of appropriate measures to ensure a fair and impartial resolution.
The investigation process will be initiated promptly upon identification of a potential conflict. This may involve gathering information from relevant parties, including authors, reviewers, and editorial staff.
Consultation with relevant stakeholders will be conducted to gain a comprehensive understanding of the situation. This may include discussions with the editorial team, legal advisors, and other experts as needed.
Based on the findings of the investigation and consultation, appropriate measures will be implemented to address the conflict. This may include re-evaluating the manuscript, changing reviewers, or other actions as deemed necessary.
Through continuous training and periodic reviews, we aim to maintain the objectivity of journal. We offer various training programs for authors, editors, reviewers, and others involved in the publication process. These programs are designed to reinforce ethical standards and promote a culture of transparency and integrity. Through periodic reviews, we address emerging challenges and align with evolving best practices in the field of scientific publishing.
We are committed to maintain strict integrity standards in scholarly publishing and regard plagiarism as serious violation of academic and ethical norms. We have a zero tolerance policy for plagiarism. To ensure the originality of the work we publish, we have implemented a comprehensive plagiarism policy. Points covered in this policy include:
Authors are encouraged to:
Authors submitting previously deposited manuscripts or theses must:
We are committed to keeping the integrity of scientific research and scrutinize any concerns that are brought to our attention by authors or readers. To address these issues thoroughly and transparently, we follow a comprehensive Correction and Retraction Policy. This policy details the procedures and outcomes related to potential errors, providing a systematic approach to uphold the credibility and reliability of the research we publish.
We support the self-archiving of articles by authors in institutional repositories or personal websites. Our Self-Archiving Policy outlines the conditions under which authors can share their work.
We are committed to the long-term preservation of the articles we publish. Our Digital Archiving and Preservation Policies outline the measures we take to ensure the accessibility and longevity of our content.
We require authors to obtain informed consent from participants in research studies. Our Informed Consent Policies outline the ethical considerations and requirements for obtaining consent.
We may accept advertising on our website, but we ensure that all advertisements are clearly distinguished from editorial content. Our Advertising Policy outlines the guidelines for accepting and displaying advertisements.
All published articles in the Nobel Journal of Health Sciences (NJHS) are distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0). This license allows users to share, copy, and adapt the work for non-commercial purposes, provided that appropriate credit is given to the original author(s) and source.
By using our website and services, you agree to the terms outlined in this Privacy Policy. If you have any questions or concerns about our privacy practices, please contact us at info@nobjohs.com.
